Monitoring follow-up
Open findings, risk categories, ownership, due dates, escalation, evidence requirements, and whether the site can see aging across studies.
Clinical trial quality consulting
Turn monitoring findings into a quality system the site can actually run.
Merindale helps research teams make monitoring follow-up, CAPA decisions, evidence of closure, inspection readiness, and recurring quality issues easier to see and easier to own.
The problem
Quality breaks down when findings become scattered work instead of an owned process.
A monitoring report can create actions for coordinators, the PI, regulatory, pharmacy, data teams, and managers at the same time. If those actions live across email, reports, spreadsheets, memory, and side conversations, the site may close items eventually without ever building a reliable quality rhythm.
Merindale helps the team centralize what matters, distinguish isolated corrections from systemic problems, clarify ownership, define closure evidence, and build a review cadence that makes repeat risk visible earlier.
We do not replace the sponsor, CRO monitor, institutional QA function, IRB, legal counsel, or regulator. We focus on the site-side operating system around the issues they surface.
What we review
From finding to correction, closure, and recurrence prevention.
The scope can be one study, one recurring issue, or a portfolio-level quality process.
CAPA decisions
Whether an issue needs a correction, root-cause analysis, formal CAPA, workflow redesign, or a different response under the site's procedures.
Inspection readiness
Documentation completeness, eTMF/eRegulatory organization, delegation and training evidence, safety and deviation workflows, and readiness gaps that should be addressed before pressure increases.
Quality feedback loop
Repeat findings, effectiveness checks, aging, trends, escalation, and the review cadence leadership needs to distinguish an isolated issue from a system problem.
A typical engagement
Make quality work visible enough to manage before it becomes an inspection narrative.
Diagnose: review monitoring reports and action logs, open CAPAs, repeat findings, aging, documentation workflows, role ownership, and the points where closure tends to stall.
Redesign: work with the responsible team to define a single action view, risk-based priority, owner, due date, closure evidence, escalation, and effectiveness checks where needed.
Transfer: leave a quality review cadence, practical tracking model, role expectations, and measures leadership can continue to use.
Typical outputs may include a monitoring action log design, remediation priorities, CAPA workflow, ownership matrix, readiness checklist, quality review cadence, and trend view.
Experience behind the service
Quality work grounded in active clinical trial operations.
The service is informed by documented site-side experience in monitoring-report review, CAPA follow-up, eTMF oversight, safety and protocol-deviation review, ICH GCP and ALCOA++ practices, sponsor/CRO coordination, training, and complex clinical-trial portfolio operations.
Repeat findings
When the same issue returns after reminders or retraining and the team needs to examine the underlying workflow.
Aging actions
When monitoring follow-up depends on email chasing and leadership cannot see what remains open across the portfolio.
Inspection readiness
When documentation, ownership, training evidence, or quality follow-up needs a disciplined pre-inspection review.
Quality process design
When the site has capable people but no repeatable operating system for findings, CAPA, escalation, and effectiveness checks.
Related guidance
Quality improves when closure becomes a system, not a chase.
Our clinical trial monitoring follow-up guide explains a practical six-step system for findings, ownership, CAPA decisions, closure evidence, and effectiveness checks.
Our site workflow handoffs guide shows how quality actions often stall between owners rather than inside a single task.
For the broader service portfolio, return to Clinical Trial Site Operations Consulting Services.
Are findings aging, repeating, or difficult to see across studies?
Bring the monitoring follow-up process you have today. We will start by identifying whether the constraint is ownership, workflow, visibility, root cause, or closure discipline.